Multiple myeloma: open trials in Netherlands

33 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT05137054
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
Trial Treatment · Phase 1 · Regeneron Pharmaceuticals
VUMC Stichting, Amsterdam · Universitair Medisch Centrum Groningen, Groningen
Registry updated 2026-11-05
NCT06189833
A study with new methods to monitor newly diagnosed multiple myeloma in participants being treated with a new treatment combination - TAURUS
Trial Treatment · Phase 2 · European Myeloma Network B.V.
Amsterdam UMC, Amsterdam · Rijnstate Ziekenhuis Stichting, Arnhem · Amphia Hospital, Breda · Universitair Medisch Centrum Groningen, Groningen · Dijklander Ziekenhuis, Hoorn Nh · Maasstad Ziekenhuis Stichting, Rotterdam
Registry updated 2026-11-04
NCT07222761
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Amphia Hospital, Breda · Spaarne Gasthuis Stichting, Hoofddorp · Radboud universitair medisch centrum Stichting, Nijmegen · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam
Registry updated 2026-11-04
NCT04634552
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Trial Treatment · Phase 2 · Janssen Research & Development, LLC
Amsterdam UMC, Amsterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-11-03
NCT05201781
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Trial Treatment · Phase 4 · Janssen Research & Development, LLC
Amsterdam UMC Stichting, Amsterdam · Universitair Medisch Centrum Groningen, Groningen · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-11-03
NCT05552222
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Amsterdam UMC Stichting, Amsterdam · Gelre Hospitals, Apeldoorn · Reinier de Graaf Groep, Delft · Zuyderland Medisch Centrum Stichting, Geleen · St. Antonius Ziekenhuis, Nieuwegein
Registry updated 2026-11-03
NCT05652335
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Amsterdam UMC, Amsterdam · METC Universitair Medisch Centrum Groningen, Groningen · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-11-03
NCT07258511
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Amsterdam UMC Stichting, Amsterdam · Universitair Medisch Centrum Groningen, Groningen · St. Antonius Ziekenhuis, Nieuwegein · Radboud universitair medisch centrum Stichting, Nijmegen · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Haga Hospital, 's-Gravenhage
Registry updated 2026-11-03
NCT07665450
A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Catharina Ziekenhuis, Eindhoven · Universitair Medisch Centrum Groningen, Groningen · Sint Antonius Ziekenhuis, Nieuwegein · Zuyderland Medical Center, Sittard-Geleen · UMCU, Utrecht
Registry updated 2026-11-03
NCT06615479
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Trial Treatment · Phase 3 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Amsterdam UMC Stichting, Amsterdam · Academisch Ziekenhuis Maastricht, Maastricht · Radboud universitair medisch centrum Stichting, Nijmegen · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-10-29
NCT05623020
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Trial Treatment · Phase 3 · Pfizer
Albert Schweitzer Ziekenhuis, Dordrecht · Universitair Medisch Centrum Groningen, Groningen
Registry updated 2026-10-27
2026-526654-14-01
A Phase 3 Study Comparing Ramantamig plus Daratumumab Versus DVRd or DRd in Participants With NDMM for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
Trial Treatment · Phase 3 · Janssen Cilag International
Catharina Ziekenhuis Stichting, Eindhoven · Zuyderland Medisch Centrum Stichting, Geleen · Universitair Medisch Centrum Groningen, Groningen · Sint Antonius Ziekenhuis Stichting, Nieuwegein · Radboud universitair medisch centrum Stichting, Nijmegen · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-10-14
NCT06980480
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Trial Treatment · Phase 3 · Takeda
Amsterdam UMC Stichting, Amsterdam · Sint Antonius Ziekenhuis Stichting, Nieuwegein
Registry updated 2026-10-13
NCT05243797
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Trial Treatment · Phase 3 · European Myeloma Network B.V.
Noordwest Ziekenhuisgroep Stichting, Alkmaar · Amsterdam UMC Stichting, Amsterdam · Albert Schweitzer Ziekenhuis, Dordrecht · Máxima Medisch Centrum, Eindhoven · Universitair Medisch Centrum Groningen, Groningen · Dijklander Ziekenhuis, Hoorn Nh · St. Antonius Ziekenhuis, Nieuwegein · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Maasstad Ziekenhuis Stichting, Rotterdam
Registry updated 2026-10-07
NCT05730036
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Albert Schweitzer Ziekenhuis, Dordrecht · Stichting Radboud University Medical Center, Nijmegen
Registry updated 2026-10-07
NCT06500884
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Trial Treatment · Phase 2 · Janssen Research & Development, LLC
Amsterdam UMC Stichting, Amsterdam · Albert Schweitzer Ziekenhuis, Dordrecht · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam
Registry updated 2026-09-25
NCT06768489
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Amsterdam UMC Stichting, Amsterdam · Universitair Medisch Centrum Groningen, Groningen · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-09-25
2023-510173-34-00
A long-term follow-up study for patients treated with Galapagos CAR T cell therapies
Trial Treatment · Phase 3 · Lakefront Biotherapeutics
Academisch Medisch Centrum, Amsterdam · Leids Universitair Medisch Centrum (LUMC), Leiden · Universiteit Maastricht, Maastricht · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam
Registry updated 2026-09-11
2022-501811-14-00
[68Ga]Ga-PentixaFor positron emission tomography for improved risk and disease assessment in myeloma
Trial Treatment · Phase 1/2 · University Of Antwerp
Amsterdam UMC, Amsterdam
Registry updated 2026-09-02
NCT07227311
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
Trial Treatment · Phase 2 · GlaxoSmithKline
Meander Medisch Centrum, Amersfoort · Spaarne Gasthuis Stichting, Hoofddorp · Haga Hospital, 's-Gravenhage
Registry updated 2026-08-25
NCT05020236
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Trial Treatment · Phase 3 · Pfizer
Academisch Ziekenhuis Maastricht, Maastricht · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam
Registry updated 2026-08-24
NCT06152575
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Trial Treatment · Phase 3 · Pfizer
Albert Schweitzer Ziekenhuis, Dordrecht · University Hospital Maastricht, Maastricht · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam
Registry updated 2026-08-24
NCT02925234
DRUP trial
Trial Treatment · Phase 2 · Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Noordwest Ziekenhuisgroep Stichting, Alkmaar · Ziekenhuisgroep Twente Stichting, Almelo · Meander Medisch Centrum Stichting, Amersfoort · OLVG Stichting, Amsterdam · Academisch Medisch Centrum, Amsterdam · Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam · Amsterdam UMC Stichting, Amsterdam · Gelre Hospitals, Apeldoorn · Rijnstate Ziekenhuis Stichting, Arnhem · Amphia Hospital, Breda · Reinier de Graaf Groep, Delft · Deventer Ziekenhuis, Deventer · Ziekenhuis Nij Smellinghe, Drachten · Ziekenhuis Gelderse Vallei Stichting, Ede Gld · Máxima Medisch Centrum, Eindhoven · Beatrix Ziekenhuis, Gorinchem · Universitair Medisch Centrum Groningen, Groningen · Stichting Martini Ziekenhuis, Groningen · Zuyderland Medisch Centrum Stichting, Heerlen · Tergooiziekenhuizen, Hilversum · Spaarne Gasthuis Stichting, Hoofddorp · Treant Ziekenhuiszorg Stichting, Hoogeveen · Medisch Centrum Leeuwarden B.V., Leeuwarden · Leids Universitair Medisch Centrum (LUMC), Leiden · Medical Center Haaglanden, Leidschendam · University Hospital Maastricht, Maastricht · Stichting Radboud Universitair Medisch Centrum, Nijmegen · Bravis Ziekenhuis, Roosendaal · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Sint Franciscus Vlietland Groep Stichting, Schiedam · Haga Hospital, 's-Gravenhage · St. Elisabeth Hospital Tilburg, Tilburg · St Antonius Ziekenhuis, Utrecht · Universitair Medisch Centrum Utrecht, Utrecht · Stichting Viecuri Medisch Centrum voor Noord-Limburg, Venlo · Isala Klinieken Stichting, Zwolle
Registry updated 2026-08-20
NCT06292780
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Trial Treatment · Phase 1/2 · Regeneron Pharmaceuticals
Amsterdam UMC Stichting, Amsterdam · Universitair Medisch Centrum Groningen, Groningen · Radboud universitair medisch centrum Stichting, Nijmegen · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-08-18
2024-513033-21-00
Long-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies
Trial Treatment · Phase 1 · USWM Ct LLC
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam
Registry updated 2026-08-14

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error